PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Clinical trial NCT07442292 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07442292
Sponsor: Peking University Cancer Hospital & Institute
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Lung Cancer (NSCLC)Lung Cancer (SCLC)Melanoma (Skin Cancer)Melanoma Metastatic PD-L1 PET / CT

Start date: 2026-02-01
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.